|
π
|
IL-1Ξ²^+ macrophages fuel pathogenic inflammation in pancreatic cancer
40 auth.
N. Caronni,
Federica La Terza,
F. M. Vittoria,
G. Barbiera,
Luca Mezzanzanica,
Vincenzo Cuzzola,
Simona Barresi,
Marta Pellegatta,
P. Canevazzi,
Garett Dunsmore,
Carlo Leonardi,
Elisa Montaldo,
Eleonora Lusito,
E. Dugnani,
A. Citro,
...
M. Ng,
M. Schiavo Lena,
Denise Drago,
A. Andolfo,
Silvia Brugiapaglia,
A. Scagliotti,
A. Mortellaro,
V. Corbo,
Zhaoyuan Liu,
A. Mondino,
P. Dellabona,
L. Piemonti,
C. Taveggia,
Claudio Doglioni,
P. Cappello,
Francesco Novelli,
M. Iannacone,
L. Ng,
F. Ginhoux,
S. Crippa,
Massimo Falconi,
Chiara Bonini,
L. Naldini,
M. Genua,
Renato Ostuni
|
6 |
2023 |
6
π
|
|
π¬
|
The dark side of immunotherapy: pancreatic cancer
G. Mucciolo,
C. Roux,
A. Scagliotti,
Silvia Brugiapaglia,
F. Novelli,
P. Cappello
|
4 |
2020 |
4
π¬
|
|
π¬
|
The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer
C. Curcio,
Silvia Brugiapaglia,
Sara Bulfamante,
Laura Follia,
P. Cappello,
F. Novelli
|
4 |
2021 |
4
π¬
|
|
π
|
HLAβDPB1*13:01 associates with enhanced, and KIR2DS4*001 with diminished protection from developing severe COVIDβ19
24 auth.
T. D. Farias,
Silvia Brugiapaglia,
Susanna Croci,
P. Magistroni,
Claudia Curcio,
Kristina Zguro,
C. Fallerini,
Francesca Fava,
Francesco Pettini,
Katherine M Kichula,
...
Nicholas R Pollock,
Neus Font-Porterias,
William H Palmer,
Wesley M. Marin,
M. Baldassarri,
M. Bruttini,
J. Hollenbach,
Audrey E Hendricks,
I. Meloni,
Francesco Novelli,
Alessandra Renieri,
Simone Furini,
Paul J. Norman,
Antonio Amoroso
|
3 |
2023 |
3
π
|
|
π
|
PI3KΞ³ inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic cancer
14 auth.
Claudia Curcio,
G. Mucciolo,
C. Roux,
Silvia Brugiapaglia,
A. Scagliotti,
Giorgia Guadagnin,
Laura Conti,
D. Longo,
Demis Grosso,
Mauro Papotti,
...
Emilio Hirsch,
P. Cappello,
J. Varner,
Francesco Novelli
|
2 |
2024 |
2
π
|
|
π
|
Circulating autoantibodies to alpha-enolase (ENO1) and far upstream element-binding protein 1 (FUBP1) are negative prognostic factors for pancreatic cancer patient survival
22 auth.
Claudia Curcio,
Tiziana Rosso,
Silvia Brugiapaglia,
Giorgia Guadagnin,
D. Giordano,
Bruno Castellino,
M. A. Satolli,
R. Spadi,
D. Campra,
Francesco Moro,
...
Mauro Papotti,
L. Bertero,
P. Cassoni,
Claudio De Angelis,
S. Langella,
A. Ferrero,
S. Armentano,
Giovanna Bellotti,
E. Fenocchio,
Annamaria Nuzzo,
G. Ciccone,
Francesco Novelli
|
2 |
2023 |
2
π
|
|
π¦
|
In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T lymphocytes and enhances their effector response to tumor-associated antigens
14 auth.
Silvia Brugiapaglia,
Sara Bulfamante,
Claudia Curcio,
Maddalena Arigoni,
Raffaele Calogero,
Lisa Bonello,
E. Genuardi,
R. Spadi,
M. A. Satolli,
D. Campra,
...
D. Giordano,
P. Cappello,
Francesca Cordero,
Francesco Novelli
|
0 |
2024 |
0
π¦
|
